2U7-10494-99925
3 vaccinations
6 coded responses
28 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 958 / CA
- Registered
- 2022-06-25
- Relationship
- Child or adolescent in my care
- Guardian
- E6U-33434-30006
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-06-25
Registered in v-safe
-
2022-06-26
Dose 1 — Pfizer-BioNTech
- 2022-06-26
-
2022-06-27
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · Fever · Fatigue or tirednessAdult check-in
- 2022-06-28
- 2022-06-29
-
2022-06-30
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Fever · Fatigue or tirednessAdult check-in
- 2022-07-01
- 2022-07-02
- 2022-07-03
- 2022-07-10
-
2022-07-17
Dose 2 — Pfizer-BioNTech
-
2022-07-18
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Fatigue or tirednessAdult check-in
-
2022-07-19
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Rhinorrhoea — Feeling: Fair · FeverFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-07-21
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Decreased appetite, Rhinorrhoea — Feeling: GoodFree text: Loss of appetite and runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-07-22
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Rhinorrhoea — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-07-23
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-07-24
- 2022-07-31
- 2022-08-07
- 2022-08-14
- 2022-08-21
- 2022-08-28
-
2022-09-16
Dose 3 — Pfizer-BioNTech
-
2022-10-06
Survey response — day 14, dose 3, dependentMedDRA: Cough, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: A week after the vaccine, Francesca developed a very high fever and cough.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-06
Report sent to call center — day 14, dose 3, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-07
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-12-16
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-26 | Pfizer-BioNTech | No |
| 2 | 2022-07-17 | Pfizer-BioNTech | No |
| 3 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-06 | Unsuccessful |
Free text
Release 12 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Runny nose
Systemic reaction (other): Runny nose
Systemic reaction (other): Loss of appetite and runny nose
Systemic reaction (other): Runny nose
Systemic reaction (other): Runny nose
Release 12 — day 14, dose 3, dependent
Symptoms: A week after the vaccine, Francesca developed a very high fever and cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release